These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. 17beta-estradiol reduces cardiac hypertrophy mediated through the up-regulation of PI3K/Akt and the suppression of calcineurin/NF-AT3 signaling pathways in rats. Wu CH; Liu JY; Wu JP; Hsieh YH; Liu CJ; Hwang JM; Lee SD; Chen LM; Chang MH; Kuo WW; Shyu JC; Tsai JH; Huang CY Life Sci; 2005 Dec; 78(4):347-56. PubMed ID: 16183079 [TBL] [Abstract][Full Text] [Related]
9. Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy. McMullen JR; Izumo S Novartis Found Symp; 2006; 274():90-111; discussion 111-7, 152-5, 272-6. PubMed ID: 17019808 [TBL] [Abstract][Full Text] [Related]
10. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Balakumar P; Jagadeesh G Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208 [TBL] [Abstract][Full Text] [Related]
11. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042 [TBL] [Abstract][Full Text] [Related]
12. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling. Muñoz JP; Collao A; Chiong M; Maldonado C; Adasme T; Carrasco L; Ocaranza P; Bravo R; Gonzalez L; Díaz-Araya G; Hidalgo C; Lavandero S Biochem Biophys Res Commun; 2009 Oct; 388(1):155-60. PubMed ID: 19654000 [TBL] [Abstract][Full Text] [Related]
13. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062 [TBL] [Abstract][Full Text] [Related]
14. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt. McDaneld TG; Spurlock DM J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171 [TBL] [Abstract][Full Text] [Related]
15. Insulin signaling: a possible pathogenesis of cardiac hypertrophy. Yu W; Chen C; Fu Y; Wang X; Wang W Cardiovasc Ther; 2010 Apr; 28(2):101-5. PubMed ID: 20398099 [TBL] [Abstract][Full Text] [Related]
16. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081 [TBL] [Abstract][Full Text] [Related]
17. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers. Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974 [TBL] [Abstract][Full Text] [Related]
18. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418 [TBL] [Abstract][Full Text] [Related]
19. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981 [TBL] [Abstract][Full Text] [Related]